DRDGOLD manager sells 5,490 vested shares at $2.75

DRDGOLD’s Financial Manager Ergo Ops. exercised 12,198 deferred equity awards and later sold 5,490 resulting Ordinary Shares while retaining 6,708 shares.

Rhea-AI Filing Summary

DRDGOLD LTD (DRD) reports that Financial Manager Ergo Ops. Ryno Bornman exercised previously awarded deferred equity and sold part of the resulting stake. On August 13, 2026, 12,198 Deferred Shares vested and were settled into the same number of Ordinary Shares for no cash consideration. A subsequent pooled sale on August 31 and September 1, 2026 disposed of 5,490 Ordinary Shares at $2.7545 per share, with the remaining 6,708 Ordinary Shares transferred into and retained in Bornman’s own name. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Bornman Ryno

Role Financial Manager Ergo Ops.

Sold 5,490 shs ($15K)

Approx. gross sale proceeds $15K

Approx. exercise cost $0.00

Type	Security	Shares	Price	Value
Sale	Ordinary Shares F2, F3	5,490	$2.7545	$15K
Exercise	Deferred Shares F1, F4	12,198	$0.00	$0.00
Exercise	Ordinary Shares F1	12,198	$0.00	$0.00

Holdings After Transaction: Deferred Shares — 57,307 contracts (Direct); Ordinary Shares — 6,708 shares (Direct)

Footnotes (4)

1. F1. On August 13, 2026, 12,198 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
2. F2. Represents 5,490 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 12,198 Deferred Shares described in footnote 1. The remaining 6,708 Ordinary Shares were transferred to and retained in the Reporting Person's own name.
3. F3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
4. F4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Key Figures

Deferred Shares vested: 12,198 shares Ordinary Shares sold: 5,490 shares Sale price per Ordinary Share: $2.7545 per share +3 more

6 metrics

Deferred Shares vested 12,198 shares Deferred Shares vested and settled one-for-one into Ordinary Shares on August 13, 2026

Ordinary Shares sold 5,490 shares Pooled sale conducted on August 31 and September 1, 2026

Sale price per Ordinary Share $2.7545 per share Average price in U.S. dollars for 5,490 Ordinary Shares sold

Sale price in ZAR ZAR 44.4764 per share Average sale price per Ordinary Share in South African rand

Ordinary Shares retained 6,708 shares Portion of Ordinary Shares from vested Deferred Shares retained by the insider

Deferred Shares exercised 12,198 shares Deferred Shares converted into Ordinary Shares for no consideration

Key Terms

Deferred Shares, Single Incentive Plan, pooled sale, South African Reserve Bank

4 terms

Deferred Shares financial

"12,198 deferred shares of DRDGOLD Limited previously awarded to the Reporting Person"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Single Incentive Plan financial

"previously awarded to the Reporting Person under the Company's Single Incentive Plan"

pooled sale financial

"Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale"

South African Reserve Bank financial

"converted from ZAR using the South African Reserve Bank exchange rate"

FAQ

What insider transactions did DRD’s Financial Manager report in this Form 4?

The Financial Manager Ergo Ops., Ryno Bornman, reported the vesting and settlement of 12,198 Deferred Shares into Ordinary Shares on August 13, 2026, followed by the sale of 5,490 Ordinary Shares in a pooled sale on August 31 and September 1, 2026, retaining 6,708 shares.

How many DRD Ordinary Shares did the insider sell and at what price?

Ryno Bornman sold 5,490 Ordinary Shares of DRDGOLD at an average price of $2.7545 per share. The transaction was originally denominated in South African rand, with an average price of ZAR 44.4764 per Ordinary Share, and then converted to U.S. dollars.

How many DRD shares did the insider retain after the pooled sale?

Of the 12,198 Ordinary Shares received from vested Deferred Shares, 6,708 Ordinary Shares were transferred to and retained in Ryno Bornman’s own name. The Form 4 notes these as retained following the pooled sale of 5,490 shares.

What was the source of the 12,198 DRD Ordinary Shares received by the insider?

The 12,198 Ordinary Shares resulted from the vesting of 12,198 Deferred Shares previously awarded under DRDGOLD’s Single Incentive Plan. On August 13, 2026, these Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration.

Were the DRD insider’s transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not marked, and the footnotes do not describe any Rule 10b5-1 or other pre-arranged trading plan. The timing is therefore not identified as being under a pre-set plan.

In what currency were the DRD share sales executed and how was the price reported?

The pooled sale of 5,490 Ordinary Shares was executed in South African rand (ZAR) at an average of ZAR 44.4764 per share. For reporting, the price was converted into U.S. dollars using the South African Reserve Bank’s exchange rate for the transaction date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:50 PM Accepted by SEC EDGAR 09/03/2026 - 04:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bornman Ryno

(Last) (First) (Middle)

CYCAD HOUSE, BUILDING 17, GROUND FLOOR

CNR 14TH AVENUE AND HENDRIK POTGIETER RD

(Street)

WELTEVREDEN PARK 1709

(City) (State) (Zip)

SOUTH AFRICA

(Country)

2. Issuer Name and Ticker or Trading Symbol
DRDGOLD LTD [ DRD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Financial Manager Ergo Ops.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/13/2026		M		12,198(1)	A	$0	12,198	D
Ordinary Shares	09/01/2026		S		5,490(2)	D	$2.7545(3)	6,708	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	$0	08/13/2026		M			12,198(1)	(1)	(1)	Ordinary Shares	12,198	$0	57,307(4)	D

Explanation of Responses:

1. On August 13, 2026, 12,198 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.

2. Represents 5,490 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 12,198 Deferred Shares described in footnote 1. The remaining 6,708 Ordinary Shares were transferred to and retained in the Reporting Person's own name.

3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.

4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Remarks:

	/s/ Ryno Bornman	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)